204 related articles for article (PubMed ID: 34214774)
1. Outcomes of transtympanic dexamethasone perfusion using the MicroWick
Kim CS; Martinez U; Mulvey E; Nayak N; Silverstein H
Am J Otolaryngol; 2021; 42(5):103138. PubMed ID: 34214774
[TBL] [Abstract][Full Text] [Related]
2. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
Suryanarayanan R; Srinivasan VR; O'Sullivan G
J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
4. [Intratympanic corticosteroid perfusion in the therapy of Meniere's disease].
Sanković-Babić S; Kosanović R; Ivanković Z; Babac S; Tatović M
Srp Arh Celok Lek; 2014; 142(5-6):291-5. PubMed ID: 25033583
[TBL] [Abstract][Full Text] [Related]
5. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
Shea PF; Richey PA; Wan JY; Stevens SR
Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
9. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
10. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
13. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
Okuda H; Aoki M; Ogawa B; Shibata H; Ueda N; Ohashi T; Hayashi H; Nishihori T; Kuze B; Ogawa T
Am J Otolaryngol; 2021; 42(6):103141. PubMed ID: 34171697
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière's disease.
Hill SL; Digges EN; Silverstein H
Ear Nose Throat J; 2006 Aug; 85(8):494, 496, 498. PubMed ID: 16999055
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
16. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
17. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
18. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
[TBL] [Abstract][Full Text] [Related]
19. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
20. [Curative effect of transtympanic perfusion of gentamicin on unilateral Ménière's disease].
Nie GH; Lu YD
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1356-8. PubMed ID: 12930695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]